These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 17195034)

  • 1. Biologic therapies in rheumatology: lessons learned, future directions.
    Strand V; Kimberly R; Isaacs JD
    Nat Rev Drug Discov; 2007 Jan; 6(1):75-92. PubMed ID: 17195034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Rheumatology--searching for the individual therapeutic cocktail].
    Hellmich B; Lamprecht P; Gross WL
    Dtsch Med Wochenschr; 2005 Jun; 130(25-26):1555-8. PubMed ID: 15965861
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapeutic advances in rheumatology with the use of recombinant proteins.
    Rothe A; Power BE; Hudson PJ
    Nat Clin Pract Rheumatol; 2008 Nov; 4(11):605-14. PubMed ID: 18813220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunomodulator therapy: monoclonal antibodies, fusion proteins, cytokines, and immunoglobulins.
    Lee SJ; Chinen J; Kavanaugh A
    J Allergy Clin Immunol; 2010 Feb; 125(2 Suppl 2):S314-23. PubMed ID: 20036416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rheumatology--past, present, and future.
    Schattenkirchner M
    Eur J Rheumatol Inflamm; 1987; 8(1):31-7. PubMed ID: 3497810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of biologic therapies in the management of systemic vasculitis.
    Chan AT; Flossmann O; Mukhtyar C; Jayne DR; Luqmani RA
    Autoimmun Rev; 2006 Apr; 5(4):273-8. PubMed ID: 16697969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging biological therapies in primary Sjogren's syndrome.
    Ramos-Casals M; Brito-Zerón P
    Rheumatology (Oxford); 2007 Sep; 46(9):1389-96. PubMed ID: 17586555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biologic therapies in non-rheumatic diseases: lessons for rheumatologists?
    Bell GM; Reynolds G; Isaacs JD
    Nat Rev Rheumatol; 2011 Aug; 7(9):507-16. PubMed ID: 21808288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New age of biological therapies in paediatric rheumatology.
    Sen ES; Ramanan AV
    Arch Dis Child; 2014 Jul; 99(7):679-85. PubMed ID: 24621445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basic science for the clinician 46. Molecular biologic agents in development: possible clinical consequences to rheumatologists.
    Sigal LH
    J Clin Rheumatol; 2007 Oct; 13(5):286-90. PubMed ID: 17921801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Historical review of rheumatology and future directions].
    Kawahata K
    Nihon Rinsho; 2009 Mar; 67(3):445-57. PubMed ID: 19280915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. At the horizon of innovative therapy in rheumatology: new biologic agents.
    Finckh A; Gabay C
    Curr Opin Rheumatol; 2008 May; 20(3):269-75. PubMed ID: 18388517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The immune tolerance network and rheumatic disease: immune tolerance comes to the clinic.
    Diamond B; Bluestone J; Wofsy D
    Arthritis Rheum; 2001 Aug; 44(8):1730-5. PubMed ID: 11508422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rheumatology in 2006: crossroads or crisis?
    Pisetsky DS
    Bull NYU Hosp Jt Dis; 2006; 64(1-2):9-11. PubMed ID: 17121482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Basic directions in the development of Soviet scientific and practical rheumatology in the last 70 years].
    Nasonova VA
    Ter Arkh; 1987; 59(10):12-7. PubMed ID: 3501616
    [No Abstract]   [Full Text] [Related]  

  • 16. Monoclonal antibodies in rheumatic diseases.
    Yuvienco C; Schwartz S
    Med Health R I; 2011 Nov; 94(11):320-4. PubMed ID: 22204094
    [No Abstract]   [Full Text] [Related]  

  • 17. Rheumatology--present status and future directions.
    Mukherjee S
    J Assoc Physicians India; 1994 Mar; 42(3):187-91. PubMed ID: 7860503
    [No Abstract]   [Full Text] [Related]  

  • 18. [Future treatment of rheumatism. A compromise in the game between inflammation and infections].
    Klareskog L; Lundberg I
    Lakartidningen; 2000 Jan; 97(1-2):30-3. PubMed ID: 10668325
    [No Abstract]   [Full Text] [Related]  

  • 19. 50th volume--60 years. A golden year.
    Scott DG; Moots RJ
    Rheumatology (Oxford); 2011 Jan; 50(1):1-3. PubMed ID: 21148152
    [No Abstract]   [Full Text] [Related]  

  • 20. New approaches of B-cell-directed therapy: beyond rituximab.
    Dörner T; Burmester GR
    Curr Opin Rheumatol; 2008 May; 20(3):263-8. PubMed ID: 18388516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.